Skip to main content
Figure 5 | BMC Immunology

Figure 5

From: Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands

Figure 5

HIV Gag-specific in vivo CTL activity. Mice (n = 4) were immunized as described in Figure 4. One week after the boost, mice received a 1 to 1 mixture of HIV Gag peptide-loaded and non-loaded syngenic donor splenocytes also differing in the intensity of the CFSE-labelling. One day after immunization, the percentage of HIV Gag peptide-loaded donor cells was determined. For reason of clarity, the level of significance in the Bonferroni Multiple Comparison test is only indicated for selected group to group comparisons (** p < 0.01).

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us